Small Bowel Obstruction in Virgin Abdomen

March 31, 2025 updated by: Liis Jaanimäe, University of Tartu

Management of Virgin Abdomen SBO With a 2-year Follow-up

A retrospective study conductet at Estonia's two regional hospitals. The data of patients hospitalised for SBO (small bowel obstruction) between 2015-2019 is retrospectively analysed. All other patients are excluded- except for previously unoperated ones (virgin abdomen). Study group analyses whether patients were operated on or was conservative management initiated. It will be studied, if any further medical studies have been done within 2 years of hospitalisation.

Study Overview

Status

Completed

Conditions

Detailed Description

Background: The surgical dogma of mandatory operative management of small bowel obstruction (SBO) in patients without prior abdominal operations was re-evaluated by the World Society of Emergency Surgery (WSES) in 2021. A few publications exist on this topic, with a modest number of patients included. The purpose of this study was to analyze the causes and management of small bowel obstruction (SBO) in patients without prior abdominal surgeries.

Methods: Study group retrospectively examined the data of patients hospitalized with SBO from 2015 to 2019. Patients without previous abdominal surgeries-virgin abdomen (VA) were included. Eligible patients' data was evaluated. It was noted whether surgery was performed or conservative management was initiated. In the latter case, information about radiological or endoscopic studies, hospitalizations, or surgeries performed within 2 years after the primary hospitalization was extracted

Study Type

Observational

Enrollment (Actual)

223

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Estonia
    • Tartumaa
      • Tartu, Tartumaa, Estonia, 51008
        • Tartu univeristy clinic

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Probability Sample

Study Population

Patients hospitalised for SBO

Description

Inclusion Criteria:

Patients diagnosed with SBO Have not been operated previously

Exclusion Criteria:

Age less than 18 years History of previous operatsions Large bowel obstruction Dynamic ileus

-

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
SBO resolution at admission
Time Frame: within hospitalisation

Patients who have been admitted. The primary outcome measure is SBO resolution within hospitalisation. Usually the conservative treatment is safe and feasible if no alarming symptoms (suggesting bowel ischaemia) are present (but can be prolonged op to 120 hours). Guidelines suggest conservative management up to 72 hours, but no clear guideline is present.

The resolution will be assessed clinically- return of bowel movement and passing of gas or radiologically- CM in the large bowel in the follow-through.
within hospitalisation

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

University of Tartu

Collaborators

North Estonia Regional Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

May 30, 2023

Primary Completion (Actual)

September 30, 2023

Study Completion (Actual)

December 21, 2023

Study Registration Dates

First Submitted

March 24, 2025

First Submitted That Met QC Criteria

March 31, 2025

First Posted (Actual)

April 4, 2025

Study Record Updates

Last Update Posted (Actual)

April 4, 2025

Last Update Submitted That Met QC Criteria

March 31, 2025

Last Verified

March 1, 2025

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • 377/T-6

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

All data generated or analyzed during this study are included in this article. Further enquiries can be directed to the corresponding author.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Small Bowel Obstruction Adhesion

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Mozambique

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe